The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vaccine Adjuvants Market Research Report 2024
Synopsis
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The global Vaccine Adjuvants market was valued at US$ 852.8 million in 2023 and is anticipated to reach US$ 1569.9 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
The top 5 global manufacturers of vaccine adjuvants are GSK, CSL Limited, Croda, SEPPIC, Novavax, which have a combined market share of about 55 percent. North America is the largest market, with a share about 38%, followed by Europe and Asia Pacific with the share about 27% and 22%.
This report aims to provide a comprehensive presentation of the global market for Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Adjuvants.
Report Scope
The Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
CSL Limited
Croda
SEPPIC
Novavax
SPI Pharma
Phibro
SDA BIO
Invivogen
Tj Kaiwei
OZ Biosciences
Brenntag Biosector
MVP Laboratories
Zhuoyue
Aphios
Segment by Type
Aluminum Adjuvant
Emulsions Adjuvant
Others
Segment by Application
Human Vaccine
Veterinary Vaccine
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The global Vaccine Adjuvants market was valued at US$ 852.8 million in 2023 and is anticipated to reach US$ 1569.9 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
The top 5 global manufacturers of vaccine adjuvants are GSK, CSL Limited, Croda, SEPPIC, Novavax, which have a combined market share of about 55 percent. North America is the largest market, with a share about 38%, followed by Europe and Asia Pacific with the share about 27% and 22%.
This report aims to provide a comprehensive presentation of the global market for Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Adjuvants.
Report Scope
The Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
CSL Limited
Croda
SEPPIC
Novavax
SPI Pharma
Phibro
SDA BIO
Invivogen
Tj Kaiwei
OZ Biosciences
Brenntag Biosector
MVP Laboratories
Zhuoyue
Aphios
Segment by Type
Aluminum Adjuvant
Emulsions Adjuvant
Others
Segment by Application
Human Vaccine
Veterinary Vaccine
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vaccine Adjuvants Market Overview
1.1 Product Overview and Scope of Vaccine Adjuvants
1.2 Vaccine Adjuvants Segment by Type
1.2.1 Global Vaccine Adjuvants Market Value Comparison by Type (2024-2030)
1.2.2 Aluminum Adjuvant
1.2.3 Emulsions Adjuvant
1.2.4 Others
1.3 Vaccine Adjuvants Segment by Application
1.3.1 Global Vaccine Adjuvants Market Value by Application: (2024-2030)
1.3.2 Human Vaccine
1.3.3 Veterinary Vaccine
1.4 Global Vaccine Adjuvants Market Size Estimates and Forecasts
1.4.1 Global Vaccine Adjuvants Revenue 2019-2030
1.4.2 Global Vaccine Adjuvants Sales 2019-2030
1.4.3 Global Vaccine Adjuvants Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vaccine Adjuvants Average Price by Manufacturers (2019-2024)
2.4 Global Vaccine Adjuvants Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine Adjuvants, Product Type & Application
2.7 Vaccine Adjuvants Market Competitive Situation and Trends
2.7.1 Vaccine Adjuvants Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaccine Adjuvants Players Market Share by Revenue
2.7.3 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccine Adjuvants Retrospective Market Scenario by Region
3.1 Global Vaccine Adjuvants Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vaccine Adjuvants Global Vaccine Adjuvants Sales by Region: 2019-2030
3.2.1 Global Vaccine Adjuvants Sales by Region: 2019-2024
3.2.2 Global Vaccine Adjuvants Sales by Region: 2025-2030
3.3 Global Vaccine Adjuvants Global Vaccine Adjuvants Revenue by Region: 2019-2030
3.3.1 Global Vaccine Adjuvants Revenue by Region: 2019-2024
3.3.2 Global Vaccine Adjuvants Revenue by Region: 2025-2030
3.4 North America Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 North America Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vaccine Adjuvants Sales by Country (2019-2030)
3.4.3 North America Vaccine Adjuvants Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccine Adjuvants Market Facts & Figures by Country
3.5.1 Europe Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vaccine Adjuvants Sales by Country (2019-2030)
3.5.3 Europe Vaccine Adjuvants Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine Adjuvants Market Facts & Figures by Country
3.6.1 Asia Pacific Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vaccine Adjuvants Sales by Country (2019-2030)
3.6.3 Asia Pacific Vaccine Adjuvants Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Latin America Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vaccine Adjuvants Sales by Country (2019-2030)
3.7.3 Latin America Vaccine Adjuvants Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine Adjuvants Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vaccine Adjuvants Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vaccine Adjuvants Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vaccine Adjuvants Sales by Type (2019-2030)
4.1.1 Global Vaccine Adjuvants Sales by Type (2019-2024)
4.1.2 Global Vaccine Adjuvants Sales by Type (2025-2030)
4.1.3 Global Vaccine Adjuvants Sales Market Share by Type (2019-2030)
4.2 Global Vaccine Adjuvants Revenue by Type (2019-2030)
4.2.1 Global Vaccine Adjuvants Revenue by Type (2019-2024)
4.2.2 Global Vaccine Adjuvants Revenue by Type (2025-2030)
4.2.3 Global Vaccine Adjuvants Revenue Market Share by Type (2019-2030)
4.3 Global Vaccine Adjuvants Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vaccine Adjuvants Sales by Application (2019-2030)
5.1.1 Global Vaccine Adjuvants Sales by Application (2019-2024)
5.1.2 Global Vaccine Adjuvants Sales by Application (2025-2030)
5.1.3 Global Vaccine Adjuvants Sales Market Share by Application (2019-2030)
5.2 Global Vaccine Adjuvants Revenue by Application (2019-2030)
5.2.1 Global Vaccine Adjuvants Revenue by Application (2019-2024)
5.2.2 Global Vaccine Adjuvants Revenue by Application (2025-2030)
5.2.3 Global Vaccine Adjuvants Revenue Market Share by Application (2019-2030)
5.3 Global Vaccine Adjuvants Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Vaccine Adjuvants Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 CSL Limited
6.2.1 CSL Limited Corporation Information
6.2.2 CSL Limited Description and Business Overview
6.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
6.2.5 CSL Limited Recent Developments/Updates
6.3 Croda
6.3.1 Croda Corporation Information
6.3.2 Croda Description and Business Overview
6.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Croda Vaccine Adjuvants Product Portfolio
6.3.5 Croda Recent Developments/Updates
6.4 SEPPIC
6.4.1 SEPPIC Corporation Information
6.4.2 SEPPIC Description and Business Overview
6.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
6.4.5 SEPPIC Recent Developments/Updates
6.5 Novavax
6.5.1 Novavax Corporation Information
6.5.2 Novavax Description and Business Overview
6.5.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novavax Vaccine Adjuvants Product Portfolio
6.5.5 Novavax Recent Developments/Updates
6.6 SPI Pharma
6.6.1 SPI Pharma Corporation Information
6.6.2 SPI Pharma Description and Business Overview
6.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
6.6.5 SPI Pharma Recent Developments/Updates
6.7 Phibro
6.6.1 Phibro Corporation Information
6.6.2 Phibro Description and Business Overview
6.6.3 Phibro Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Phibro Vaccine Adjuvants Product Portfolio
6.7.5 Phibro Recent Developments/Updates
6.8 SDA BIO
6.8.1 SDA BIO Corporation Information
6.8.2 SDA BIO Description and Business Overview
6.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
6.8.5 SDA BIO Recent Developments/Updates
6.9 Invivogen
6.9.1 Invivogen Corporation Information
6.9.2 Invivogen Description and Business Overview
6.9.3 Invivogen Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Invivogen Vaccine Adjuvants Product Portfolio
6.9.5 Invivogen Recent Developments/Updates
6.10 Tj Kaiwei
6.10.1 Tj Kaiwei Corporation Information
6.10.2 Tj Kaiwei Description and Business Overview
6.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
6.10.5 Tj Kaiwei Recent Developments/Updates
6.11 OZ Biosciences
6.11.1 OZ Biosciences Corporation Information
6.11.2 OZ Biosciences Vaccine Adjuvants Description and Business Overview
6.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
6.11.5 OZ Biosciences Recent Developments/Updates
6.12 Brenntag Biosector
6.12.1 Brenntag Biosector Corporation Information
6.12.2 Brenntag Biosector Vaccine Adjuvants Description and Business Overview
6.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
6.12.5 Brenntag Biosector Recent Developments/Updates
6.13 MVP Laboratories
6.13.1 MVP Laboratories Corporation Information
6.13.2 MVP Laboratories Vaccine Adjuvants Description and Business Overview
6.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
6.13.5 MVP Laboratories Recent Developments/Updates
6.14 Zhuoyue
6.14.1 Zhuoyue Corporation Information
6.14.2 Zhuoyue Vaccine Adjuvants Description and Business Overview
6.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
6.14.5 Zhuoyue Recent Developments/Updates
6.15 Aphios
6.15.1 Aphios Corporation Information
6.15.2 Aphios Vaccine Adjuvants Description and Business Overview
6.15.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Aphios Vaccine Adjuvants Product Portfolio
6.15.5 Aphios Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine Adjuvants Industry Chain Analysis
7.2 Vaccine Adjuvants Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine Adjuvants Production Mode & Process
7.4 Vaccine Adjuvants Sales and Marketing
7.4.1 Vaccine Adjuvants Sales Channels
7.4.2 Vaccine Adjuvants Distributors
7.5 Vaccine Adjuvants Customers
8 Vaccine Adjuvants Market Dynamics
8.1 Vaccine Adjuvants Industry Trends
8.2 Vaccine Adjuvants Market Drivers
8.3 Vaccine Adjuvants Market Challenges
8.4 Vaccine Adjuvants Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
